ASTION PHARMA A/S: Financial statements 2020
CVR: 34224781
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,602,554 and a net result of DKK -4,807,562 compared with DKK -1,767,025 the year before. Equity in the 2020 report amounted to DKK 697,176. The solvency ratio was 6.6%.
- Gross Profit
- DKK -3,602,554
- Profit/Loss
- DKK -4,807,562
- Equity
- DKK 697,176
- Total Assets
- DKK 10,515,820
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -3.6 mio. | -4.8 mio. | 697 t. | - |
| 2019 | - | -1.8 mio. | -1.8 mio. | - | - |
| 2018 | - | -392 t. | -409 t. | 500 t. | - |
| 2017 | - | -48 t. | -1.5 mio. | 7.7 mio. | 0 |
| 2016 | - | -187 t. | 117 t. | 15.7 mio. | 0 |
Official annual report
How creditworthy is ASTION PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ASTION PHARMA A/S has published its annual report for 2019. Gross profit came to DKK -1,831,910, and the net result was DKK -1,767,025.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.